These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30407653)

  • 1. Expectant long-term follow-up of patients with chronic urinary retention.
    Abello A; DeWolf WC; Das AK
    Neurourol Urodyn; 2019 Jan; 38(1):305-309. PubMed ID: 30407653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the conservative management of chronic retention in men ever justified?
    Bates TS; Sugiono M; James ED; Stott MA; Pocock RD
    BJU Int; 2003 Oct; 92(6):581-3. PubMed ID: 14511038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic urinary retention in men: how we define it, and how does it affect treatment outcome.
    Negro CL; Muir GH
    BJU Int; 2012 Dec; 110(11):1590-4. PubMed ID: 22452619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of conservatively managed acute urinary retention: prostate size matters.
    Kumar V; Marr C; Bhuvangiri A; Irwin P
    BJU Int; 2000 Nov; 86(7):816-9. PubMed ID: 11069406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
    Ghalayini IF; Al-Ghazo MA; Pickard RS
    BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications.
    Alivizatos G; Ferakis N; Mitropoulos D; Skolarikos A; Livadas K; Kastriotis I
    J Endourol; 2005; 19(1):72-8. PubMed ID: 15735388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
    Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
    J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention.
    Jaeger CD; Mitchell CR; Mynderse LA; Krambeck AE
    BJU Int; 2015 Feb; 115(2):295-9. PubMed ID: 24552209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
    Khan M; Khan AL; Khan S; Nawaz H
    J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
    Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
    Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the Rezum system for the treatment of catheter-dependent urinary retention: Three-year real-world outcomes in a multimorbid, multiethnic population.
    Babar M; Masoud Z; Labagnara K; Loloi J; Sayed R; Singh S; Tang K; Syed U; Ciatto M
    Low Urin Tract Symptoms; 2023 Jul; 15(4):148-153. PubMed ID: 37190924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction.
    Lin YH; Hou CP; Chen TH; Juang HH; Chang PL; Yang PS; Chen CL; Tsui KH
    BMC Geriatr; 2018 Jan; 18(1):15. PubMed ID: 29338688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, Safety, and Durability of 532 nm Laser Photovaporization of the Prostate with GreenLight 180 W XPS in Men with Acute Urinary Retention.
    Goueli R; Meskawi M; Thomas D; Hueber PA; Tholomier C; Valdivieso R; Te A; Zorn KC; Chughtai B
    J Endourol; 2017 Nov; 31(11):1189-1194. PubMed ID: 28844169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral Bipolar Enucleation of the Prostate Is an Effective Treatment Option for Men With Urinary Retention.
    Tracey JM; Warner JN
    Urology; 2016 Jan; 87():166-71. PubMed ID: 26498734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine.
    Luo F; Sun HH; Su YH; Zhang ZH; Wang YS; Zhao Z; Li J
    Lasers Med Sci; 2017 May; 32(4):895-901. PubMed ID: 28293871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia.
    Narayan P; Tewari A; Fournier G; Toke A
    Urology; 1995 May; 45(5):776-82. PubMed ID: 7538239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-energy transurethral microwave thermotherapy in patients with acute urinary retention due to benign prostatic hyperplasia.
    Djavan B; Seitz C; Ghawidel K; Basharkhah A; Bursa B; Hruby S; Marberger M
    Urology; 1999 Jul; 54(1):18-22. PubMed ID: 10414720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial radiofrequency therapy of the prostate in the management of acute urinary retention.
    Makar AA; Thomas PJ; Fletcher MS; Harrison NW
    Br J Urol; 1998 May; 81(5):726-9. PubMed ID: 9634049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia.
    McVary KT; Holland B; Beahrs JR
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):303-308. PubMed ID: 31740738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.